Sort
48,018 grants matching “immunotherapy”
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform
$421,501Tania Tali Konry · Northeastern University · R33 · FY2018 · CA
Shared Resource: Therapeutic Manufacturing
$421,498Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2018 · CA
Shared Resource: Therapeutic Manufacturing
$421,497Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2019 · CA
T memory stem cells in cancer
$421,488Yiping Yang · Duke University · R01 · FY2016 · CA
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$421,462Jordan Scott Orange · Columbia University Health Sciences · R01 · FY2019 · AI
Combining AD epitope vaccine with innate immunity
$421,437David Hastings Cribbs · University Of California-Irvine · R01 · FY2008 · NS
Combining AD epitope vaccine with innate immunity
$421,423David Hastings Cribbs · University Of California-Irvine · R01 · FY2007 · NS
Improving anti-tumor immunity in advanced breast cancer by targeting solid stress
$421,414Dennis Jones · Boston University Medical Campus · R01 · FY2025 · CA
Combining AD epitope vaccine with innate immunity
$421,368David Hastings Cribbs · University Of California-Irvine · R01 · FY2006 · NS
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$421,360Xiumei Huang · Indiana University Indianapolis · R01 · FY2020 · CA
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma
$421,346Shumei Song · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Elucidating the role of T-regs in engraftment, GVHD, and DLI immunotherapy
$421,324Christene A Huang · Massachusetts General Hospital · R01 · FY2012 · AI
Shared Resource: Therapeutic Manufacturing
$421,294Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2016 · CA
Project 2
$421,290David A Barbie · Dana-Farber Cancer Inst · P50 · FY2022 · CA
IMMUNOLOGICAL MONITORING AND CELLULAR PRODUCTS LABORATORY
$421,214Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2014 · CA
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2021 · AG
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2022 · AG
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
$421,107Jamie Berta Spangler · Johns Hopkins University · R01 · FY2021 · EB
Determining how neutrophil activities contribute to antibiotic treatment failure
$421,067Brian Patrick Conlon · Univ Of North Carolina Chapel Hill · R21 · FY2025 · AI
Immunophenotype Integration for Monitoring T Cell Dynamics in Pancreatic Cancers
$421,042Won Jin Ho · Johns Hopkins University · R21 · FY2021 · CA
Signaling functions of Peli family of E3 ubiquitin ligases
$421,034Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation
$421,032Tyrone Porter · Boston University (Charles River Campus) · R01 · FY2015 · EB
Intra- and inter-cellular signals that drive hepato-oncogenesis
$421,010Gen-Sheng Feng · University Of California, San Diego · R01 · FY2020 · CA
TECH Core
$420,957Kevin William Eliceiri · University Of Minnesota · U54 · FY2024 · CA
VIRAHEP-C: A multi-center, collaborative clinical trial
$420,870University Of Michigan At Ann Arbor · M01 · FY2004 · RR